Valhi, Inc. (VHI) Stock Price & Analysis
Valhi, Inc. (VHI) closed at USD 14.33 on Thursday, October 22, 2026, up 2.58% on the day. The US market is currently closed (pre-market); this is not a live price.
The prior close was USD 14.33; the Oct 22, 2026 session ranged USD 13.99–14.33 on volume of 5,489 shares. Market capitalization is —, with a 52-week range of USD 11.44–19.19 (NYQ). Source: Nexqual, retrieved October 23, 2026 at 11:03 UTC.
Also available as compact Markdown for AI agents: nexqual.com/VHI.md
Key facts (VHI)
- Last four reported quarters (through Jun 30, 2026): revenue $2.16B, net income -$51.1M (-2.4% margin), free cash flow $62.7M (SEC filings).
- Total return with dividends: 1Y +1.7% vs S&P 500 +14.9%; 5Y -34.2% vs S&P 500 +80.3%.
- Next earnings: 2026-11-05, EPS estimate USD —, revenue estimate $0K.
Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters) (VHI)
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | TTM |
|---|---|---|---|---|---|---|
| Revenue | $2.30B | $2.22B | $1.92B | $2.10B | $2.08B | $2.16B |
| Gross profit | $580M | $490M | $245M | $425M | $295M | — |
| Operating income | $319M | $239M | $34.2M | $211M | $63.3M | $78.3M |
| Net income | $127M | $87.2M | -$9.9M | $108M | -$57.6M | -$51.1M |
| EPS (diluted) | $4.46 | $3.06 | -$0.35 | $3.79 | -$2.02 | — |
| Free cash flow | $396M | -$32.7M | -$44.6M | $13.1M | -$82.1M | $62.7M |
| Gross margin | 25.3% | 22.1% | 12.8% | 20.2% | 14.2% | — |
| Operating margin | 13.9% | 10.8% | 1.8% | 10.0% | 3.0% | 3.6% |
| Net margin | 5.5% | 3.9% | -0.5% | 5.1% | -2.8% | -2.4% |
| Revenue growth | +24.1% | -3.2% | -13.5% | +9.5% | -1.3% | — |
| Cash + short-term investments | $701M | $554M | $463M | $350M | $217M | — |
| Total debt | $653M | $560M | $547M | $563M | $592M | — |
Fiscal years end Dec. EPS is split-adjusted.
Valuation (price ÷ last four quarters, through Jun 30, 2026) (VHI)
P/S 0.2x · EV/EBITDA 5.3x · EV/Sales 0.4x · P/FCF 6.5x · P/B 0.4x · FCF yield 15.45% · Earnings yield -12.59% · Dividend yield (paid, TTM) 2.24% · Net debt $375M · EV $781M
P/E at fiscal year-ends: Dec 2024 6.2x.
Total return (dividends reinvested) (VHI)
| 1Y (from 2025-10-23) | 5Y (from 2021-10-18) | |
|---|---|---|
| Total return | +1.7% | -34.2% |
| S&P 500 (SPY) | +14.9% | +80.3% |
| Per year | +1.7% | -8.0% |
| Volatility (annualized) | 49.3% | 56.7% |
| Max drawdown | -25.1% (Sep 2026→Oct 2026) | -76.9% (May 2022→Oct 2023) |
VHI revenue by business segment (quarter ended Jun 30, 2026)
| Line | Revenue | Share of total | YoY |
|---|---|---|---|
| Chemicals | $558.1M | 92.1% | +12.9% |
| Component Products | $43.6M | 7.2% | +8.2% |
| Real Estate Management & Development | $4.4M | 0.7% | -22.8% |
| Total revenue | $606.1M | 100% | — |
VHI revenue by product line (quarter ended Jun 30, 2026)
| Line | Revenue | Share of total | YoY |
|---|---|---|---|
| Security Products | $33.3M | 5.5% | +8.5% |
| Marine Components | $10.3M | 1.7% | +7.3% |
| Total revenue | $606.1M | 100% | — |
As tagged by the company in its SEC 10-Q / 10-K filings (XBRL).
VHI suppliers, customers and competitors (named in its 10-K)
| Relationship | Company | Sentence in the filing |
|---|---|---|
| Partner | Contran | “We are a party to a tax sharing agreement with Contran providing for the allocation of tax liabilities and tax payments as described in Note 1.” |
| Partner | Louisiana Pigment Company | “Gain on Remeasurement of Investment in TiO2 Manufacturing Joint Venture – We recognized a gain on the remeasurement of Kronos' investment in LPC of $64.5 million in the third quarter of 2024 as a result of the acquisition.” |
Quoted from the company's 10-K filed Mar 10, 2026.
VHI analyst estimates and revisions
| Period | EPS estimate | 90 days ago | Change | Revenue estimate | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends Jun 2025) | — | — | — | $0 | — |
| Next quarter | — | — | — | $0 | — |
| Current fiscal year (ends Dec 2025) | — | — | — | $0 | — |
| Next fiscal year | — | — | — | $0 | — |
Key Statistics (as of October 23, 2026 at 11:03 UTC)
| Price | USD 14.33 |
|---|---|
| Change | ▲ 2.58% (up) |
| Previous Close | USD 14.33 |
| Open | USD 14.33 |
| Day Range | USD 13.99 – 14.33 |
| 52-Week Range | USD 11.44 – 19.19 |
| Volume | 5,489 shares |
| Market Cap | — |
| Exchange | NYQ |
Technical Analysis (VHI)
Nexqual's technical model rates VHI "STRONG SELL" based on 0 bullish and 5 bearish signals across 127 daily candles, as of October 23, 2026 at 11:03 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 36.77 (neutral) |
| vs SMA50 | Below (USD 16.36) |
| MACD | -0.58 (negative) |
Earnings (VHI)
| Next Earnings Date | 2026-11-05 |
|---|
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2025-03-31 | USD 0.59 vs est 0.66 ▼ miss |
| 2024-12-31 | USD 2.84 vs est 0.6 ▲ beat |
| 2024-09-30 | USD 0.4 vs est 1 ▼ miss |
| 2024-06-30 | USD 0.73 vs est 0.29 ▲ beat |
Source: Nexqual, October 23, 2026 at 11:03 UTC.
Financials & Fundamentals (VHI)
| Total Revenue | $2.16B |
|---|---|
| Revenue Growth (latest quarter, YoY) | +12.20% |
| Gross Margin | +14.88% |
| Operating Margin | +6.68% |
| Profit Margin | -2.36% |
| ROE | -2.96% |
| Debt / Equity | 0.43 |
| Current Ratio | 3.37 |
| Total Cash | $212.40M |
| Total Debt | $607.40M |
| Free Cash Flow (last four quarters to Jun 2026, SEC 10-Q / 10-K) | $62.70M (2.9% of revenue) |
Source: Nexqual, October 23, 2026 at 11:03 UTC.
Financial Health Score (VHI)
Nexqual rates Valhi, Inc.'s overall financial health "Weak" across five dimensions, as of October 23, 2026 at 11:03 UTC.
| Growth | Weak — Revenue -0% YoY (annual), declining |
|---|---|
| Profitability | Weak — Gross margin 15%, operating 7% (last 12 months) |
| Balance Sheet | Strong — $212M cash and investments vs $588M debt (Jun 2026, SEC) |
| Cash Flow | Mixed — FCF $63M (last 4 quarters to Jun 2026, SEC), slim 2.9% margin |
| Efficiency | Critical — ROE -3%, ROA 0.4% |
Ownership (VHI)
| Insider Ownership | +91.55% |
|---|---|
| Institutional Ownership | +4.20% |
| Shares Outstanding | 28.32M |
| Float | 2.40M |
| Short % of Float | +2.74% |
Source: Nexqual, October 23, 2026 at 11:03 UTC.
From Valhi, Inc.'s Latest SEC 10-K Filing (filed 2026-03-10)
Key Strengths & Strategy (as disclosed to the SEC)
- Kronos expects to spend approximately $13 million on research and development in 2026.
- The TiO2 industry is characterized by high barriers to entry consisting of high capital costs, proprietary technology and significant lead times required to construct new facilities or to expand existing capacity.
Partnerships
- In most instances buyers can cancel an escrow agreement with no financial penalties until shortly before the closing date.
Legal & Regulatory Risks (Item 1A, quoted)
- We could incur significant costs related to legal and environmental remediation matters.
- Environmental, health and safety laws and regulations may result in increased regulatory scrutiny which could decrease demand for our products, increase our manufacturing and compliance costs or obligations and result in unanticipated losses which could negatively impact our financial results or limit our ability to operate our Chemicals Segment's business.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| ASIX | AdvanSix Inc. | USD 15.68 | ▲ 1.55% |
| BAK | Braskem SA | USD 1.6 | ▼ 2.44% |
| RYAM | Rayonier Advanced Materials Inc | USD 6.83 | ▼ 2.29% |
| TROX | Tronox Holdings plc | USD 3.48 | ▲ 6.75% |
| LXU | LSB Industries, Inc. | USD 9.76 | ▼ 5.33% |
| WLKP | Westlake Chemical Partners LP | USD 20.96 | ▲ 0.43% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 23, 2026 at 11:03 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt